FDA avisory panel recommends decreasing Acetaminophen dosage
스크롤 이동 상태바
FDA avisory panel recommends decreasing Acetaminophen dosage
기자명
메디칼라이터팀
입력 2009.07.07 00:00
수정 2009.07.07 09:45
댓글 0
According to the Deputy director of the FDA"s Office of New Drugs at the Center for Drug Evaluation and Research, Dr Sandra KwederI, the top recommendation of the advisory panel was that the agency needs to address and decrease the usual dose of acetaminophen, both for over-the-counter products and also prescription combination products. The FDA panel suggests banning Percocet [oxycodone and acetaminophen] and Vicodin [hydrocodone bitartrate and acetaminophen]which experts say would not be drastic due to other drugs being available.